Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Biotech Stocks
Biotech Stocks
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Is Gearing Towards An Unmet Need Opioid Approval
-
September 15, 2016
Is Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?
Here’s What The ArQule, Inc. (NASDAQ:ARQL) Data Really Means
Pay For CEO Of Boston Scientific Corporation (NYSE:BSX) Increases In 2016 As Revenues Grow
Pfizer Inc. (NYSE:PFE) Issues XELJANZ Results, Collaborates With Western Oncolytics For WO-12
What We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)...
-
August 23, 2016
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Scores Big, But Have The Children?
-
April 28, 2017
0
What’s Next For Esperion Therapeutics Inc (NASDAQ:ESPR)?
-
February 6, 2017
0
Biotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant...
David Rich
-
July 29, 2016
0
A Closer Look At The Biogen Alzheimer’s DoubleDown
Jennifer Aldershot
-
October 21, 2015
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD): Breaking Down The Raise
-
December 15, 2016
0
High Risk, High Reward on Telesta’s Panel Review
ME Staff
-
November 13, 2015
1
Here’s Why a Relypsa Inc (NASDAQ:RLYP) Buyout is Risky Before May...
ME Staff
-
April 8, 2016
0
Why The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity
-
September 14, 2016
0
Beigene Ltd (ADR) (NASDAQ:BGNE): Here’s Our Take
-
January 26, 2017
0
1
...
144
145
146
Page 146 of 146
/* */
// AST – IMS - [MarketExclusive_ROS]
Edit with Live CSS